Xilis, a startup founded by two professors at Duke University focusing on technology to boost precision health and oncology, has landed $70 million in new funding with Google Ventures among the backers.
The two-year-old company had previously raised close to $5 million.
“Our vision is to transform cancer care in diagnostics and reshape drug development by providing a technology for rapid therapeutic profiling,” said Xiling Shen, founder and CEO of Xilis, in Thursday’s announcement.. “The support provided by these world-class investors is an important milestone for our journey to transform cancer care and dramatically improve patient survival by enabling personalized precision oncology and bringing transformative medicines to patients faster and with higher success rates.”
Xilis focuses on what it calls MicroOrganoSphere (MOS) technology to not only assist precision therapy delivery for cancer patients but also to accelerate drug discovery and development.
Source: Durham medtech startup Xilis raises $70M; Google Ventures, Duke Angels among backers | WRAL TechWire
